期刊文献+

FOXQ1和E-cadherin在食管鳞状细胞癌中的表达及临床意义 被引量:7

Expression levels and clinical significance of FOXQ1 and E-cadherin in esophageal squamous cell carcinoma
暂未订购
导出
摘要 目的探讨叉头框蛋白Q1(FOXQ1)和E-钙黏蛋白(E-cadherin)在食管鳞状细胞癌(ESCC)中的表达及临床意义。方法采用免疫组织化学法检测42例ESCC组织(ESCC组)及其癌旁正常食管鳞状上皮组织(正常组)中FOXQ1和E-cadherin的表达情况,分析其表达与患者临床病理特征及预后的关系。结果 ESCC组FOXQ1的阳性表达率高于正常组(64.29%vs 28.57%,χ2=5.384,P<0.05),E-cadherin的阳性表达率低于正常组(52.38%vs 90.48%,χ2=7.691,P<0.05)。FOXQ1的表达强度在不同TNM分期及不同淋巴结转移情况间的差异有统计学意义,E-cad-herin的表达强度在不同浸润深度、分化程度、TNM分期和淋巴结转移情况间的差异有统计学意义。ESCC组织中FOXQ1和E-cadherin的表达呈负相关(r=-0.412,P<0.05)。FOXQ1高表达者的5年生存率低于低表达者(18.52%vs 66.67%,χ2=9.737,P<0.05),E-cadherin高表达者的5年生存率高于低表达者(59.09%vs 10.00%,χ2=10.996,P<0.05)。COX比例风险回归模型分析结果显示,FOXQ1高表达、E-cadherin低表达、有淋巴结转移是影响ESCC患者预后的独立危险因素。结论 FOXQ1和E-cadherin在ESCC组织中的表达呈现较好的相关性,联合检测两者的表达对于ESCC患者的预后判断及指导治疗具有一定的临床价值。 Objective To investigate the expression levels and clinical significance of(forkhead box Q1) FOXQ1 andE-cadherin in esophageal squamous cell carcinoma(ESCC). Methods Expression levels of FOXQ1 and E-cadherin werein ESCC tissues(ESCC group, n=42) and adjacent normal esophageal tissues(control group, n=42) were detected using im-munohistochemistry. Correlations of FOXQ1 and E-cadherin expressions with clinical pathological parameters and progno-sis were analyzed between two groups. Results The expression level of FOXQ1 was significantly higher in ESCC groupthan that in control group(64.29% vs 28.57%,χ^2=5.384,P〈0.05). The expression level of E-cadherin was significantlylower in ESCC group than that incontrol group(52.38% vs 90.48%,χ2=7.691,P〈0.05). There were significant differencesin FOXQ1 expressions between different TNM stages and whether lymph node metastasis is involved within ESCC group.There were significant differences in expression of E-cadherin between different tumor differentiation, depth of invasion,TNM stage and whether lymph node metastasis is involved within ESCC group. The expression of FOXQ1 was negatively cor-related with E-cadherin in ESCC(r =-0.412, P〈0.05). The 5-year survival rates were significantly lower with high expres-sion of FOXQ1 or with low expression of FOXQ1(18.52% vs 66.67%,χ^2=9.737,P〈0.05). The 5-year survival rates weresignificantly higher with high expression of E-cadherinor low expression of E-cadherin(59.09% vs 10.00%,χ^2=10.996,P〈0.05). A multivariate Cox's proportional hazard regression analysis indicated that high FOXQ1 expression, low E-cadherinexpression and lymph node metastasis were independent prognostic factors for ESCC. Conclusion The expression ofFOXQ1 and E-cadherin showed a good correlation with ESCC. And examining expressions of both FOXQ1 and E-cadherinin ESCC may have practical values in estimating the prognosis of ESCC and directing future treatment.
出处 《天津医药》 CAS 2015年第2期170-174,I0004,共6页 Tianjin Medical Journal
关键词 食管肿瘤 鳞状细胞 钙黏着糖蛋白类 预后 免疫组织化学 叉头框蛋白Q1 E-钙黏蛋白 esophageal neoplasms carcinoma squamous cell cadherins prognosis immunohistochemistry forkhead box Q1 E-cadherin
  • 相关文献

参考文献11

  • 1郑荣寿,张思维,吴良有,李光琳,赵平,赫捷,陈万青.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12. 被引量:564
  • 2Zhang H, Meng F, Liu G, et al. Forkhead transcription factor foxq 1 pro- motes epithelial-mesenchymal transition and breast cancer metastasis [J]. Cancer'Res, 2011, 71(4):1292-1301. doi: 10.1158/0008- 5472.CAN-10-2825.
  • 3Reinhold WC, Reimers MA, Lorenzi P, et al. Multifactorial regula- tion of E-cadherin expression: an integrative study[J]. Mol Cancer Ther, 2010, 9(1):1-16. doi: 10.1158/1535-7163.MCT-09-0321.
  • 4Liang S, Yan X, Wang B, et al. Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer[J]. Tumor Biol, 2013, 34(5): 2605-2609. doi:10.1007/s13277-013-0808-x.
  • 5Feng J, Zhang X, Zhu H, et al. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT[J]. PLoS One, 2012, 7(6): e39937.doi:10.1371/ journal.pone.O039937.
  • 6刘朝阳,高绘菊,牟志美,刘庆信.转录调控因子Fox的功能及分子机制研究进展[J].昆虫学报,2013,56(3):312-322. 被引量:5
  • 7谭祎媚,张逊,徐美林,王菁,徐医军.RhoB和E-cadherin在非小细胞肺癌组织中的表达及临床意义[J].天津医药,2014,42(1):27-30. 被引量:6
  • 8李昌秀,徐红梅,杨达荣,杨柳,吴时军,张黎,罗治彬.CD147 PTEN E-钙黏蛋白在食管癌组织中表达与临床病理的关系[J].检验医学与临床,2013,10(2):129-131. 被引量:8
  • 9Rao U S, Hoerster N S, Thirumala S, et al. The influence of metastat- ic site on the expression of CEA and cellular localization of 13- catenin in colorectal cancer[J]. Journal of Gastroenterology and Hep- atology,2013, 28(3): 505-512. doi:10.1111/jgh.12083.
  • 10Stubbins RE, Hakeem A, Ntifiez NP. Using components of the vita- min D pathway to prevent and treat colon cancer[J]. Nutr Rev, 2012, 70(12): 721-729.doi:10.1111/j. 1753-4887.2012.00522.x.

二级参考文献108

共引文献579

同被引文献56

  • 1袁林,徐又先,沈世强,卢欣.血清E-钙黏连蛋白在肝细胞癌手术前后的表达及术后复发的意义[J].肿瘤防治研究,2014,41(2):153-156. 被引量:4
  • 2Lee JM, Turini M, Botteman MF, et al. Economic burden of head and neck cancer[J]. Eur J Health Econ, 2004,5(1):70-80. doi: 10.1007/s 10198 --003 -0204-3.
  • 3Burusapat C, Jarungroongruangchai W, Charoenpitakchai M. Prog- nostic factors of cervical node status in head and neck squamous cell carcinoma[J]. World J Surg Oncol, 2015,13(1):51. doi: 10.1186/ s 12957-015-0460-6.
  • 4Kim M, Lira J, Yang Y, et al. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial - mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling[J]. Cancer Lett, 2014,354(1):33-42. doi: 10.1016/j.canlet.2014.06.023.
  • 5Smith A, Teknos TN, Pan Q. Epithelial to mesenchymal transition in head and neck squamous cell carcinoma[J].Oral Oncol, 2013,49 (4):287-292. doi: 10.1016/j.oraloncology.2012.10.009.
  • 6Ehrlich SM, Liebl J, Ardelt MA, et al. Targeting cyclin dependent kinase 5 in hepatocellular carcinoma-A novel therapeutic approach[J]. J Hepatol, 2015,63(1):102-113. doi: 10.1016/j.jhep.2015.01.031.
  • 7Ren Y, Zhou X, Yang J, et al. AC1MMYR2 impairs high dose pacli- taxel-induced tumor metastasis by targeting miR-21/CDK5 axis[J]. Cancer Lett, 2015,362(2):174-182. doi: 10.1016/j.canlet.2015.03.038.
  • 8Liang Q, Li L, Zhang J, et al. CDK5 is essential for TGF-betal-in- duced epithelial-mesen'chymal transition and breast cancer progres- sion[J]. Sci Rep, 2013,3:2932. doi: 10.1038/srep02932.
  • 9Pozo K, Castro-Rivera E, Tan C, et al. The role of Cdk5 in neuroen- docrine thyroid caneer[J]. Cancer Cell, 2013,24(4):499-511. doi: 10.1016/j.cer.2013.08.027.
  • 10Feldmann G, Mishra A, Hong SM, et al. Inhibiting the cyclin-de- pendent kinase edk5 blocks pancreatic cancer formation and pro- gression through the suppression of ras-ral signaling[J]. Cancer Res, 2010,70(11):4460-4469.doi: 10.1158/0008-5472.CAN-09-1107.

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部